• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型β-内酰胺抗生素替莫西林(BRL 17421)的体外活性

In vitro activity of temocillin (BRL 17421), a novel beta-lactam antibiotic.

作者信息

Van Landuyt H W, Pyckavet M, Lambert A, Boelaert J

出版信息

Antimicrob Agents Chemother. 1982 Oct;22(4):535-40. doi: 10.1128/AAC.22.4.535.

DOI:10.1128/AAC.22.4.535
PMID:7181470
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC183789/
Abstract

The minimal inhibitory concentration of temocillin (BRL 17421) against 476 clinical isolates was determined by an agar dilution method. Temocillin was active against most of the Enterobacteriaceae, Haemophilus, and Neisseria strains tested. The compound showed low activity or was inactive against Bacteroides, Campylobacter, Acinetobacter, Pseudomonas, and Staphylococcus aureus strains. Within each species, individual strains showed a high degree of uniformity in their susceptibility to temocillin; the drug concentrations that inhibited the growth of 90% of organisms were the same or close to those which inhibited the growth of 50% of organisms. In contrast, the same strains showed a very wide range of susceptibility to the other antibiotics tested, including third-generation cephalosporins. Against strains of Enterobacteriaceae highly susceptible to third-generation cephalosporins, temocillin was considerably less active than cefotaxime, ceftazidime, and moxalactam, although it was more active than cefazolin and piperacillin. Against certain strains of Enterobacter and Citrobacter resistant to third-generation cephalosporins, temocillin was more active than cefotaxime and ceftazidime. An increase in the inoculum size did not alter the activity of temocillin, indicating that the compound has high stability to beta-lactamases. The minimal lethal concentration was also very similar to the minimal inhibitory concentration when an inoculum of 10(5) colony-forming units was used.

摘要

采用琼脂稀释法测定替莫西林(BRL 17421)对476株临床分离菌的最低抑菌浓度。替莫西林对大多数测试的肠杆菌科细菌、嗜血杆菌和奈瑟菌菌株具有活性。该化合物对拟杆菌、弯曲杆菌、不动杆菌、假单胞菌和金黄色葡萄球菌菌株显示出低活性或无活性。在每个菌种内,各个菌株对替莫西林的敏感性表现出高度一致性;抑制90%菌生长的药物浓度与抑制50%菌生长的浓度相同或接近。相比之下,相同菌株对包括第三代头孢菌素在内的其他测试抗生素表现出非常广泛的敏感性范围。对于对第三代头孢菌素高度敏感的肠杆菌科细菌菌株,替莫西林的活性明显低于头孢噻肟、头孢他啶和拉氧头孢,尽管它比头孢唑林和哌拉西林更具活性。对于某些对第三代头孢菌素耐药的肠杆菌和柠檬酸杆菌菌株,替莫西林比头孢噻肟和头孢他啶更具活性。接种量的增加并未改变替莫西林的活性,表明该化合物对β-内酰胺酶具有高度稳定性。当使用10(5)个菌落形成单位的接种量时,最低致死浓度也与最低抑菌浓度非常相似。

相似文献

1
In vitro activity of temocillin (BRL 17421), a novel beta-lactam antibiotic.新型β-内酰胺抗生素替莫西林(BRL 17421)的体外活性
Antimicrob Agents Chemother. 1982 Oct;22(4):535-40. doi: 10.1128/AAC.22.4.535.
2
In vitro activity of temocillin against clinical isolates.
Drugs. 1985;29 Suppl 5:1-8. doi: 10.2165/00003495-198500295-00003.
3
Antibacterial activity and beta-lactamase stability of temocillin.替莫西林的抗菌活性及β-内酰胺酶稳定性
Antimicrob Agents Chemother. 1982 Sep;22(3):453-60. doi: 10.1128/AAC.22.3.453.
4
In vitro activity of temocillin, moxalactam and cefotaxime against gram negative bacteria sensitive or resistant to ureidopenicillins and/or cefacedone.
Zentralbl Bakteriol Mikrobiol Hyg A. 1983 Dec;256(2):202-10.
5
In vitro antibacterial properties of BRL 36650, a novel 6 alpha-substituted penicillin.新型6α-取代青霉素BRL 36650的体外抗菌特性
Antimicrob Agents Chemother. 1984 Nov;26(5):734-40. doi: 10.1128/AAC.26.5.734.
6
Comparative in vitro study of temocillin (BRL 17421), a new penicillin.新型青霉素替莫西林(BRL 17421)的体外比较研究
Antimicrob Agents Chemother. 1982 Apr;21(4):641-5. doi: 10.1128/AAC.21.4.641.
7
Comparative in-vitro activity of temocillin (BRL 17421), a new penicillin.新型青霉素替莫西林(BRL 17421)的体外活性比较
J Antimicrob Chemother. 1983 Apr;11(4):319-24. doi: 10.1093/jac/11.4.319.
8
Temocillin. In vitro activity compared with other antibiotics.
Drugs. 1985;29 Suppl 5:91-7. doi: 10.2165/00003495-198500295-00018.
9
Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.氧杂β-内酰胺类LY127935、头孢噻肟、头孢哌酮、头孢孟多和替卡西林对多重耐药革兰氏阴性杆菌的比较活性。
Antimicrob Agents Chemother. 1980 Feb;17(2):273-9. doi: 10.1128/AAC.17.2.273.
10
In vitro activity of temocillin (BRL 17421), a novel beta-lactamase-stable penicillin.替莫西林(BRL 17421)的体外活性,一种新型的β-内酰胺酶稳定青霉素。
Antimicrob Agents Chemother. 1982 Jul;22(1):157-61. doi: 10.1128/AAC.22.1.157.

引用本文的文献

1
Analysis of ESAC-Net/EARS-Net Data from 29 EEA Countries for Spatiotemporal Associations Between Antimicrobial Use and Resistance-Implications for Antimicrobial Stewardship?对来自29个欧洲经济区国家的ESAC-Net/EARS-Net数据进行分析,以研究抗菌药物使用与耐药性之间的时空关联——对抗菌药物管理有何启示?
Antibiotics (Basel). 2025 Apr 13;14(4):399. doi: 10.3390/antibiotics14040399.
2
Clinical and microbiological evaluation of temocillin for bloodstream infections with Enterobacterales: a Belgian single-centre retrospective study.替莫西林治疗肠杆菌科细菌血流感染的临床和微生物学评价:一项比利时单中心回顾性研究
JAC Antimicrob Resist. 2022 Aug 23;4(4):dlac086. doi: 10.1093/jacamr/dlac086. eCollection 2022 Aug.
3
Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.哌拉西林。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1984 Nov;28(5):375-425. doi: 10.2165/00003495-198428050-00002.
4
In vitro combination-effect of temocillin with ticarcillin and aminoglycosides on gram-negative and gram-positive bacteria.替莫西林与替卡西林及氨基糖苷类药物对革兰氏阴性菌和革兰氏阳性菌的体外联合效应。
Drugs. 1985;29 Suppl 5:74-7. doi: 10.2165/00003495-198500295-00015.
5
Comparative in vitro activity of temocillin.替莫西林的体外活性比较
Drugs. 1985;29 Suppl 5:24-31. doi: 10.2165/00003495-198500295-00007.
6
Renal clearance of temocillin in volunteers.
Drugs. 1985;29 Suppl 5:128-34. doi: 10.2165/00003495-198500295-00027.
7
Pharmacokinetics and tissue penetration of temocillin.替莫西林的药代动力学及组织穿透性
Drugs. 1985;29 Suppl 5:106-8. doi: 10.2165/00003495-198500295-00022.
8
In vitro activity of temocillin against clinical isolates.
Drugs. 1985;29 Suppl 5:1-8. doi: 10.2165/00003495-198500295-00003.
9
Temocillin in the treatment of gram-negative septicaemia.替莫西林治疗革兰阴性菌败血症
Drugs. 1985;29 Suppl 5:182-5. doi: 10.2165/00003495-198500295-00039.
10
Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.头孢他啶。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1985 Feb;29(2):105-61. doi: 10.2165/00003495-198529020-00002.

本文引用的文献

1
BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans.BRL 17421是一种新型β-内酰胺抗生素,对β-内酰胺酶具有高度抗性,在人体内可产生高且持久的血清浓度。
Antimicrob Agents Chemother. 1981 Jul;20(1):38-46. doi: 10.1128/AAC.20.1.38.
2
Comparative in vitro study of temocillin (BRL 17421), a new penicillin.新型青霉素替莫西林(BRL 17421)的体外比较研究
Antimicrob Agents Chemother. 1982 Apr;21(4):641-5. doi: 10.1128/AAC.21.4.641.
3
In vitro activity of BRL 17421 against Haemophilus influenzae, Neisseria gonorrhoeae, and Branhamella catarrhalis.BRL 17421对流感嗜血杆菌、淋病奈瑟菌和卡他布兰汉菌的体外活性。
Antimicrob Agents Chemother. 1982 Jan;21(1):166-7. doi: 10.1128/AAC.21.1.166.
4
Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.一种使用显色头孢菌素底物检测β-内酰胺酶的新方法。
Antimicrob Agents Chemother. 1972 Apr;1(4):283-8. doi: 10.1128/AAC.1.4.283.